[Features of neurological manifestations of the COVID-19 in children and adults].
A A KholinNikolay N ZavadenkoYu E NesterovskiyE A KholinaA N ZavadenkoG Sh KhondkaryanPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
The number of COVID-19 patients is increasing worldwide and the number of patients with neurological manifestations of a new coronavirus infection is increasing as well. Pathognomonic for COVID-19 is the presence of cephalgic syndrome, infectious-toxic encephalopathy, hypo- and anosmia and ageusia. Inducing of pathological autoimmune response contributes to the development of Miller Fischer and Guillain-Barré syndrome. Hyperergic reaction with the generation of the so-called «cytokine storm» provokes multisystem hemorrhagic complications such as Kawasaki disease and acute necrotizing hemorrhagic encephalopathy. There is also a special form of COVID-19-associated stroke. Almost all post-COVID-19 patients complain of severe fatigue, emotional lability, and sometimes have features of asthenic-neurotic, anxiety-phobic disorders and apato-abulic syndromes, which require rehabilitation measures, as well as courses of restorative neurotrophic and nootropic therapy.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- early onset
- drug induced
- atrial fibrillation
- liver failure
- multiple sclerosis
- sleep quality
- stem cells
- cerebral ischemia
- risk factors
- brain injury
- bone marrow
- mesenchymal stem cells
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- subarachnoid hemorrhage
- blood brain barrier
- smoking cessation
- electron transfer